1. Home
  2. NDAQ vs EW Comparison

NDAQ vs EW Comparison

Compare NDAQ & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDAQ
  • EW
  • Stock Information
  • Founded
  • NDAQ 1971
  • EW 1958
  • Country
  • NDAQ United States
  • EW United States
  • Employees
  • NDAQ N/A
  • EW N/A
  • Industry
  • NDAQ Investment Bankers/Brokers/Service
  • EW Industrial Specialties
  • Sector
  • NDAQ Finance
  • EW Health Care
  • Exchange
  • NDAQ Nasdaq
  • EW Nasdaq
  • Market Cap
  • NDAQ 49.1B
  • EW 44.8B
  • IPO Year
  • NDAQ 2002
  • EW 2000
  • Fundamental
  • Price
  • NDAQ $90.07
  • EW $76.79
  • Analyst Decision
  • NDAQ Buy
  • EW Buy
  • Analyst Count
  • NDAQ 16
  • EW 20
  • Target Price
  • NDAQ $87.93
  • EW $80.20
  • AVG Volume (30 Days)
  • NDAQ 3.5M
  • EW 3.6M
  • Earning Date
  • NDAQ 07-24-2025
  • EW 07-23-2025
  • Dividend Yield
  • NDAQ 1.20%
  • EW N/A
  • EPS Growth
  • NDAQ 18.52
  • EW 200.69
  • EPS
  • NDAQ 2.21
  • EW 7.02
  • Revenue
  • NDAQ $7,816,000,000.00
  • EW $5,522,300,000.00
  • Revenue This Year
  • NDAQ N/A
  • EW $11.81
  • Revenue Next Year
  • NDAQ $6.99
  • EW $9.54
  • P/E Ratio
  • NDAQ $40.75
  • EW $10.93
  • Revenue Growth
  • NDAQ 25.96
  • EW 8.23
  • 52 Week Low
  • NDAQ $59.95
  • EW $58.93
  • 52 Week High
  • NDAQ $90.35
  • EW $95.25
  • Technical
  • Relative Strength Index (RSI)
  • NDAQ 75.32
  • EW 53.38
  • Support Level
  • NDAQ $88.17
  • EW $76.30
  • Resistance Level
  • NDAQ $89.64
  • EW $78.07
  • Average True Range (ATR)
  • NDAQ 1.20
  • EW 1.49
  • MACD
  • NDAQ 0.04
  • EW 0.14
  • Stochastic Oscillator
  • NDAQ 94.62
  • EW 71.52

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as the firm seeks to become a diversified technology company.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: